1,084
Views
29
CrossRef citations to date
0
Altmetric
Review

Neoadjuvant chemotherapy in cervical cancer: an update

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ling Xu, Yao Tan, Ping Xiang, Yu Luo, Jia Peng, Hong Xiao & FuChun Liu. (2023) Diet-Related Risk Factors for Cervical Cancer: Data from National Health and Nutrition Examination Survey 1999–2018. Nutrition and Cancer 75:10, pages 1892-1899.
Read now
Tong Tong, Qiong Fan, Shu Shi, Yuhong Li & Yudong Wang. (2023) Gastric-type mucinous adenocarcinoma of the cervix in a woman with Peutz-Jeghers syndrome: a case report. Acta Chirurgica Belgica 123:4, pages 448-453.
Read now
Jiayi Xiong, Juanjuan Sheng, Yan Wei, Zhimin Sun, Xia Xiao & Lanmei Zhang. (2022) Sesamol Augments Paclitaxel-Induced Apoptosis in Human Cervical Cancer Cell Lines. Nutrition and Cancer 74:10, pages 3692-3700.
Read now
Luigi Della Corte, Fabio Barra, Virginia Foreste, Pierluigi Giampaolino, Giulio Evangelisti, Simone Ferrero & Giuseppe Bifulco. (2020) Advances in paclitaxel combinations for treating cervical cancer. Expert Opinion on Pharmacotherapy 21:6, pages 663-677.
Read now

Articles from other publishers (24)

Yingjie Hu, Yingyan Han, Yuanming Shen, Jing Chen, Yaheng Chen, Yile Chen, Junying Tang, Min Xue, Li Hong, Wenjun Cheng, Danbo Wang, Zhiqing Liang, Yifeng Wang, Qinghua Zhang, Hui Xing, Yu Zhang, Cunjian Yi, Zhiying Yu, Youguo Chen, Manhua Cui, Cailing Ma, Hongying Yang, Ruizhen Li, Ping Long, Yu Zhao, Pengpeng Qu, Guangshi Tao, Lihua Yang, Sufang Wu, Zhihua Liu, Ping Yang, Weiguo Lv, Xing Xie, Ding Ma, Hui Wang & Kezhen Li. (2022) Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial. BMC Cancer 22:1.
Crossref
Kangni Zou, E. Yang, Tao Cui & Zhengyu Li. (2022) Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer. Frontiers in Oncology 12.
Crossref
Azma Baharudin, Zainab Yahaya & Habibah Abdul Hamid. (2022) Progression of Disease with Neo-Adjuvant Chemotherapy in Locally Advanced Cervical Cancer: Case Reports and Literature Review. European Journal of Medical and Health Sciences 4:3, pages 20-23.
Crossref
Yibao Huang, Qingqing Zhu, Liru Xue, Xiaoran Zhu, Yingying Chen & Mingfu Wu. (2022) Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer. Frontiers in Oncology 12.
Crossref
Huang Jing, Wu Xiuhong, Yu Ying, Liao Zhenrong, Cheng Xiyun, Luo Deping, Shen Changmei, Wang Qi, Peng Tao & Pan Yiyun. (2021) Neoadjuvant chemotherapy combined with radical surgery for stage IB2/IIA2 cervical squamous cell carcinoma: a prospective, randomized controlled study of 35 patients. World Journal of Surgical Oncology 19:1.
Crossref
Setareh Akhavan, Abbas Alibakhshi, Mahdieh Parsapoor, Abbas Alipour & Elahe Rezayof. (2021) Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2). BMC Cancer 21:1.
Crossref
Chen Cao, Ting Liu, Qinghua Zhang, Rui Li, Zhen Zeng, Zifeng Cui, Xin Wang, Danni Gong, Xun Tian & Zheng Hu. (2021) Somatic mutations and CRISPR/Cas9 library screening integrated analysis identifies cervical cancer drug‐resistant pathways. Clinical and Translational Medicine 11:12.
Crossref
Yong-Xia Li, Jian-Ying Chang, Ming-Yuan He, He-Ran Wang, Dai-Qin Luo, Feng-Hu Li, Jie-Hui Li & Li Ran. (2021) Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer. Journal of Oncology 2021, pages 1-14.
Crossref
Antonios Athanasiou, Sarah J Bowden, Evangelos Paraskevaidis, T S Shylasree, Kostas Lathouras & Maria Kyrgiou. (2021) Neoadjuvant chemotherapy and surgery versus chemoradiotherapy for locally advanced cervical cancer. Cochrane Database of Systematic Reviews 2021:7.
Crossref
Yunbao Xu, Mengting Zhang, Jiaying Zhang, Derry Minyao Ng, Xiaoxiao Chen, Yuexiu Si, Yetan Shi, Xiangyuan Li, Danyi Mao & Lu Yang. (2021) Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis. Taiwanese Journal of Obstetrics and Gynecology 60:3, pages 433-441.
Crossref
Xun Tian, Xin Wang, Zifeng Cui, Jia Liu, Xiaoyuan Huang, Caixia Shi, Min Zhang, Ting Liu, Xiaofang Du, Rui Li, Lei Huang, Danni Gong, Rui Tian, Chen Cao, Ping Jin, Zhen Zeng, Guangxin Pan, Meng Xia, Hongfeng Zhang, Bo Luo, Yonghui Xie, Xiaoming Li, Tianye Li, Jun Wu, Qinghua Zhang, Gang Chen & Zheng Hu. (2021) A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer. Advanced Science 8:10, pages 2001978.
Crossref
Zhengjie Ou, Dan Zhao, Bin Li, Yating Wang, Shuanghuan Liu & Yanan Zhang. (2021) A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy. Cancer Research and Treatment 53:1, pages 233-242.
Crossref
Xinhua Qu, Liumei Zhu, Linlin Song & Shaohua Liu. (2020) circ_0084927 promotes cervical carcinogenesis by sponging miR-1179 that suppresses CDK2, a cell cycle-related gene. Cancer Cell International 20:1.
Crossref
Lu Zhang, Wanyue Wang, Shanqiang Zhang, Yuxin Wang, Weikang Guo, Yunduo Liu, Yaoxian Wang & Yunyan Zhang. (2020) Identification of lysine acetylome in cervical cancer by label-free quantitative proteomics. Cancer Cell International 20:1.
Crossref
V. N. Zhurman, I. V. Pezhenin, I. V. Sayapina, L. S. Matyushkina & Eliseeva Eliseeva. (2020) The effectiveness of neoadjuvant chemotherapy in the treatment of cervical cancer (clinical case). Hirurg (Surgeon):11-12, pages 28-39.
Crossref
Yue He, Su-Bin Han, Yu-Ning Geng, Shu-Li Yang & Yu-Mei Wu. (2020) Quantitative analysis of proteins related to chemoresistance to paclitaxel and carboplatin in human SiHa cervical cancer cells via iTRAQ. Journal of Gynecologic Oncology 31:3.
Crossref
Serena Saladini, Michele Aventaggiato, Federica Barreca, Emanuela Morgante, Luigi Sansone, Matteo A. Russo & Marco Tafani. (2019) Metformin Impairs Glutamine Metabolism and Autophagy in Tumour Cells. Cells 8:1, pages 49.
Crossref
Sophie Espenel, Max Adrien Garcia, Julien Langrand-Escure, Alexis Vallard, Jane Chloé Trone, Chloé Rancoule, Nicolas Vial, Pablo Moreno-Acosta, Céline Chauleur, Claire Boutet, Michel Peoc'h, Nathalie Prevot-Bitot, Jean Baptiste Guy & Nicolas Magné. (2019) Special Focus on Stage IV Cervical Cancer Patients: A Decade Experience. Oncology 97:3, pages 125-134.
Crossref
Yunshan Zhu, Jianhua Yang, Xiao Zhang, Danxia Chen & Songying Zhang. (2018) Acquired treatment response from neoadjuvant chemotherapy predicts a favorable prognosis for local advanced cervical cancer. Medicine 97:17, pages e0530.
Crossref
Shu Chen, Miaomiao Tao, Lingqiong Zhao & Xianquan Zhang. (2017) The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients. Medicine 96:40, pages e7981.
Crossref
Hongyu Chen, Wei Zhang, Xiang Cheng, Liang Guo, Shuai Xie, Yuanfang Ma, Ning Guo & Ming Shi. (2017) β2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells. Cancer Science 108:7, pages 1310-1317.
Crossref
Peter de Boer, Ina M. Jürgenliemk-Schulz, Henrike Westerveld, Astrid A.C. de Leeuw, Raquel Dávila-Fajardo, Coen R.N. Rasch, Bradley R. Pieters & Lukas J.A. Stalpers. (2017) Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer. Radiotherapy and Oncology 123:2, pages 306-311.
Crossref
Dirk Michael Forner & Peter Mallmann. (2017) Neoadjuvant and definitive chemotherapy or chemoradiation for stage III and IV vulvar cancer: A pooled Reanalysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 212, pages 115-118.
Crossref
Eric Romney, Whitney Wilson, Justin Chen, Trung Nguyen, Omar Jawhar, Aniket Mody, Shaleen Korch & Vinay J Nagaraj. (2017) Sanguinarine-Mediated Sensitization of Cervical Cancer SiHa Cells to TRAIL. Journal of Cancer Therapy 08:06, pages 624-635.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.